Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS: JULY ISSUE PUBLISHED
  • JULY 2021 Issue has been successfully launched on 1 July 2021.

Abstract

REVIEW ON ANALYTICAL METHODS FOR QUANTITATIVE ESTIMATION OF REMOGLIFLOZIN ETABONATE AND METFORMIN HYDROCHLORIDE IN PHARMACEUTICAL DOSAGE FORM

Patel Bhumika M.*

ABSTRACT

Remogliflozin etabonate chemical name is Ethyl [(2R, 3S, 4S, 5R, 6S)-3,4,5 trihydroxy-6-{[ 5 methyl-1-(propan-2-yl) -4-{[4-(propan-2-yloxy) phenyl] methyl}-1H-pyrazol-3-yl] oxy} oxan-2-yl ] methyl carbonate.Metformin hydrochloride chemical name is 3-(diaminomethylidene)-1,1- dimethyl guanidine; hydrochloride. This both drugs used as anti-hyperglycemic agent. Remogliflozin etabonate is Inhibitor of Sodium-Glucose Co-transpoter-2 that is responsible for glucose reabsorption in the kidney, blocking this transporter causes blood glucose to be eliminated from the urine; it is a selective SGLT-2. Metformin hydrochloride is decreasing in blood glucose by decreasing hepatic glucose production, decreasing in intestinal absorption of glucose and by improving insulin sensitivity by increasing the peripheral glucose uptake neutralization. All of this are mediated by ability of metformin to activate AMPk- activated protein kinase. So, both this combination is used as anti-hyperglycemic agent. A comprehensive literature review is prepared for Remogliflozin etabonate and metformin hydrochloride.

Keywords: Remogliflozin etabonate, Metformin hydrochloride, Anti-hyperglycemic agent, Analytical methods.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More